Dr. Lecturer Kerem Kırna gave information about how hemophilia disease emerged, its diagnosis, symptoms and treatment. Stating that hemophilia is a disease that manifests itself as a result of the blood not clotting properly, the bleeding does not stop or stops late, Dr. Kırna said that this is a rare hereditary disease.


Kırnacı emphasized that this disease is the result of factor VIII or IX deficiency and “Factor VIII deficiency is called Hemophilia A, factor IX deficiency Hemophilia B. Hemophilia A accounts for 85 percent of hemophilia, and Hemophilia B about 15 percent. Hemophilia is inherited from parents to children. The disease is mostly passed on from carrier women to boys (although rarely women can get sick). “Hemophilia developed in 30 percent of the patients without a family history.”


Kırnacı pointed out that the occurrence of easy bruising on the skin during childhood, especially the formation of intra-articular and intramuscular spontaneous bleeding, and the long-lasting bleeding history after intervention or trauma suggest hemophilia. Pain and limitation of movement in the joints with bleeding, bleeding in the skin (bruising), gum bleeding, bleeding after tooth extraction, post-circumcision bleeding, unusual bleeding after vaccines, bleeding in the baby’s skull after a difficult birth, blood in urine or stool, frequent and symptoms such as nosebleeds that are difficult to stop, and heavy menstrual bleeding that can last for a long time in girls may indicate the disease, ”he said.


Continuing his words by explaining the process of diagnosing the disease, Kırnacı said, “For the diagnosis, tests are made to measure the clotting activity in the blood. Tests are also done to measure the amount of clotting factors in the blood. With the test results, the type and degree of hemophilia can be determined according to the amount of factor in the blood, ”he said.

Kırnacı emphasized that hemophilia treatment is performed by replacing the missing factor with a new one, and said, “Factor concentrates are used for this. Treatment is performed periodically in severe and moderate patients as a preventive measure. In addition, the factor is used in therapeutic doses at the time of bleeding. He ended his words by saying “Preventive treatment is applied in the preparation period of the tooth extraction or surgical operation of the hemophilia patient”.

Leave a Reply

Your email address will not be published. Required fields are marked *